1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Decerebrate Posturing in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamitani, T; Katamoto, M; Katsuta, K; Kikuchi, H; Kumada, S; Ono, T; Tatsumi, M | 1 |
Shiga, T; Yoshikawa, D | 1 |
Mikulaschek, AW; Toth, PD | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Decerebrate Posturing
Article | Year |
---|---|
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Atrial Function; Blood Pressure; Bronchi; Decerebrate State; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasodilation; Vasodilator Agents | 1984 |
Platelet-activating factor-induced loss of vascular responsiveness to noradrenaline in pithed rats: involvement of nitric oxide.
Topics: Analysis of Variance; Animals; Arginine; Cyclooxygenase Inhibitors; Decerebrate State; Enzyme Inhibitors; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar; Vasomotor System | 1995 |
Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Topics: Animals; Blood Pressure; Decerebrate State; Male; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Shock, Hemorrhagic; Shock, Septic; Thiazoles | 1986 |